Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry.

Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, Krapf L, Lewalter T, Merioua I, Murin J, Naditch-Brûlé L, Ponikowski P, Rosenqvist M, Silva-Cardoso J, Zharinov O, Brette S, Neill JO; RealiseAF investigators.

Heart. 2012 Feb;98(3):195-201. doi: 10.1136/heartjnl-2011-300550. Epub 2011 Sep 22.

PMID:
21948959
2.

Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.

Chiang CE, Naditch-Brûlé L, Murin J, Goethals M, Inoue H, O'Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, Lewalter T, Rosenqvist M, Steg PG.

Circ Arrhythm Electrophysiol. 2012 Aug 1;5(4):632-9. doi: 10.1161/CIRCEP.112.970749. Epub 2012 Jul 11.

3.

Insights into management of atrial fibrillation in Asia Pacific gained from baseline data from REgistry on cardiac rhythm disORDers (RecordAF-Asia Pacific [AP]) registry.

Amerena J, Chen SA, Sriratanasathavorn C, Cho JG, Huang D, Omar R, Tse HF, King A.

Am J Cardiol. 2012 Feb 1;109(3):378-82. doi: 10.1016/j.amjcard.2011.08.046. Epub 2011 Nov 24.

PMID:
22118827
4.

[Health-related quality of life of patients with atrial fibrillation managed by cardiologists: MOVE study].

Kirch W, Pittrow D, Bosch RF, Kohlhaussen A, Willich SN, Rosin L, Bonnemeier H; MOVE-Studiengruppe.

Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S26-32. doi: 10.1055/s-0030-1249205. Epub 2010 Mar 10. German.

PMID:
20221975
5.

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W.

J Am Coll Cardiol. 2011 Jul 26;58(5):493-501. doi: 10.1016/j.jacc.2011.03.034.

6.

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC; RACE Study Group.

J Am Coll Cardiol. 2004 Jan 21;43(2):241-7.

PMID:
14736444
7.

Baseline characteristics of patients from Poland enrolled in the global registry of patients with recently diagnosed atrial fibrillation (RecordAF).

Opolski G, Kosior DA, Kurzelewski M, Skrzyńska M, Zagórski A, Janion M, Muzolf M, Wlazłowski R, Pankiewicz B, Łoboz-Grudzień K, Breithardt G; Polish RecordAF.

Kardiol Pol. 2010 May;68(5):546-54.

8.

Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).

Ha AC, Breithardt G, Camm AJ, Crijns HJ, Fitzmaurice GM, Kowey PR, Le Heuzey JY, Naditch-Brûlé L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub WS, Dorian P.

Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):896-904. doi: 10.1161/HCQ.0000000000000011. Epub 2014 Nov 11.

9.

Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T Jr, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.

Am Heart J. 2005 Jan;149(1):112-20.

PMID:
15660042
10.

Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.

Ahmed S, Ranchor AV, Crijns HJ, Van Veldhuisen DJ, Van Gelder IC; CONVERT investigators.

Europace. 2010 Jun;12(6):785-91. doi: 10.1093/europace/euq049. Epub 2010 Mar 2.

PMID:
20200016
11.

Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, Chang P, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Circ Cardiovasc Qual Outcomes. 2015 Jul;8(4):393-402. doi: 10.1161/CIRCOUTCOMES.114.001303. Epub 2015 Jun 9.

12.

Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study.

Grönefeld GC, Lilienthal J, Kuck KH, Hohnloser SH; Pharmacological Intervention in Atrial Fibrillation (PIAF) Study investigators.

Eur Heart J. 2003 Aug;24(15):1430-6.

PMID:
12909072
13.

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.

Heart. 2009 Jun;95(11):924-30. doi: 10.1136/hrt.2008.158931. Epub 2009 Mar 11.

PMID:
19282313
14.

Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation.

Arribas F, Ormaetxe JM, Peinado R, Perulero N, Ramírez P, Badia X.

Europace. 2010 Mar;12(3):364-70. doi: 10.1093/europace/eup421. Epub 2010 Jan 6.

PMID:
20056594
15.

Complexity of atrial fibrillation patients and management in Chinese ethnicity in routine daily practice: insights from the RealiseAF Taiwanese cohort.

Wang KL, Wu CH, Huang CC, Wu TC, Naditch-Brûlé L, Steg PG, Lin SJ, Chiang CE.

J Cardiol. 2014 Sep;64(3):211-7. doi: 10.1016/j.jjcc.2014.01.010. Epub 2014 Mar 3.

16.

Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.

Silva-Cardoso J, Zharinov OJ, Ponikowski P, Naditch-Brûlé L, Lewalter T, Brette S, Steg PG; RealiseAF Investigators.

Clin Cardiol. 2013 Dec;36(12):766-74. doi: 10.1002/clc.22209. Epub 2013 Sep 17.

17.

Functional status in rate- versus rhythm-control strategies for atrial fibrillation: results of the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Functional Status Substudy.

Chung MK, Shemanski L, Sherman DG, Greene HL, Hogan DB, Kellen JC, Kim SG, Martin LW, Rosenberg Y, Wyse DG; AFFIRM Investigators.

J Am Coll Cardiol. 2005 Nov 15;46(10):1891-9. Epub 2005 Oct 21.

18.

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM, Mitchell LB, Roy D, Skanes AC, Rose MS, Wyse DG.

Circ Arrhythm Electrophysiol. 2009 Jun;2(3):218-24. doi: 10.1161/CIRCEP.108.812347. Epub 2009 Mar 31.

19.

Evaluation of atrial fibrillation (AF) management and cardiovascular risk profile in AF patients: data from Turkish patients in the international observational cross-sectional REALISE AF trial.

Diker E, Bellur G, Yıldız N, İzgi C, Naditch-Brûlé L.

Turk Kardiyol Dern Ars. 2015 Jan;43(1):60-74. doi: 10.5543/tkda.2015.93530.

20.

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure.

Suman-Horduna I, Roy D, Frasure-Smith N, Talajic M, Lespérance F, Blondeau L, Dorian P, Khairy P; AF-CHF Trial Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):455-60. doi: 10.1016/j.jacc.2012.10.031. Epub 2012 Dec 19.

Supplemental Content

Support Center